Risk assessment for infected endocarditis in


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 25 10 2017
medline: 16 4 2020
entrez: 25 10 2017
Statut: ppublish

Résumé

Echocardiography is the main technique for the diagnosis of endocarditis in patients with Data from SAB patients admitted from 2012 to 2014 were collected. We tested the Palraj scores to stratify patients' risk for endocarditis. Moreover, we analyzed our population to identify any other possible clinical predictors of endocarditis not included in the score. Endocarditis was diagnosed in 38 of 205 patients (18.5%). Palraj's score was effective in the detection of patients at high risk of endocarditis. In addition, we identified the presence of cardiac devices, prolonged bacteremia and intravenous drug abuse (IVDA) as elements strongly correlated with endocarditis. Two scoring systems (Day-1 and Day-5) were derived including IVDA as a variable. Using a Day-1 cut-off value ≥5 and a Day-5 cut-off value ≥2, the 'modified Palraj's score' showed sensitivities of 42.1% and 97.0% and specificities of 88.6% and 32.0% for Day-1 and Day-5 scores, respectively. We modify and expand upon an effective scoring system to identify SAB patients at high risk for endocarditis in order to guide use of TEE. The inclusion of IVDA in the criteria for the calculation of the scores improves its effectiveness.

Identifiants

pubmed: 29064261
doi: 10.1177/2048872617735809
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

476-484

Auteurs

Luca Longobardo (L)

1 Department of Clinical and Experimental Medicine - Section of Cardiology, University of Messina, Italy.

Sarah Klemm (S)

2 Aurora St. Luke's Medical Center, Milwaukee, USA.
3 Antibiotic Stewardship Program, Aurora Health Care, Milwaukee, USA.

Margaret Cook (M)

2 Aurora St. Luke's Medical Center, Milwaukee, USA.
3 Antibiotic Stewardship Program, Aurora Health Care, Milwaukee, USA.

Valerie Ravenna (V)

4 Medical Science Liaison, Theravance Biopharma, Inc., San Francisco, CA, USA.

Charles F Brummitt (CF)

2 Aurora St. Luke's Medical Center, Milwaukee, USA.
3 Antibiotic Stewardship Program, Aurora Health Care, Milwaukee, USA.
5 University of Wisconsin School of Medicine and Public Health, Milwaukee, USA.

Tadele Mengesha (T)

6 Aurora Research Institute, Milwaukee, USA.

Bijoy K Khandheria (BK)

5 University of Wisconsin School of Medicine and Public Health, Milwaukee, USA.
7 Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke's Medical Centers, Milwaukee, WI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH